We are live on ! Find out more
UFF

USA Financial Formulas Portfolio holdings

AUM $531M
1-Year Est. Return 28.6%
This Fund
S&P 500
This Quarter Est. Return
-15.75%
1 Year Est. Return
+28.6%
3 Year Est. Return
+77.97%
5 Year Est. Return
10 Year Est. Return
AUM
$402M
AUM Growth
+$6.86M
Cap. Flow
-$20.3M
Cap. Flow %
-5.06%
Top 10 Hldgs %
23.97%
Holding
446
New
176
Increased
44
Reduced
107
Closed
119

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$10.4M
2
COST icon
Costco
COST
+$8.5M
3
PFE icon
Pfizer
PFE
+$7.82M
4
NKE icon
Nike
NKE
+$7.56M
5
ROST icon
Ross Stores
ROST
+$7.11M

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$14.9M
2
INTC icon
Intel
INTC
+$13.3M
3
FISV
Fiserv Inc
FISV
+$9.29M
4
BA icon
Boeing
BA
+$8.92M
5
JBHT icon
JB Hunt Transport Services
JBHT
+$7.67M

Sector Composition

Rank Sector Weight
1 Healthcare 24.56%
2 Technology 17.99%
3 Consumer Discretionary 13.18%
4 Industrials 13.18%
5 Financials 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TYL icon
101
Tyler Technologies
TYL
$12.7B
$625K 0.16%
2,549
-977
-28% -$193K
ADUS icon
102
Addus HomeCare
ADUS
$2.16B
$623K 0.16%
+8,882
New +$607K
OPLN
103
Openlane
OPLN
$4.21B
$620K 0.15%
+27,456
New +$569K
BEAT
104
DELISTED
BioTelemetry, Inc.
BEAT
$620K 0.15%
+9,622
New +$578K
CHE icon
105
Chemed
CHE
$7.07B
$608K 0.15%
1,902
+1,024
+117% +$309K
LGND icon
106
Ligand Pharmaceuticals
LGND
$5.76B
$605K 0.15%
+3,535
New +$377K
RGEN icon
107
Repligen
RGEN
$7.96B
$603K 0.15%
+10,874
New +$638K
AXON
108
Axon Enterprise
AXON
$42.5B
$593K 0.15%
8,662
+94
+1% +$4.88K
CAT icon
109
Caterpillar
CAT
$375B
$590K 0.15%
3,871
+888
+30% +$116K
QLYS icon
110
Qualys
QLYS
$5.1B
$587K 0.15%
6,589
-566
-8% -$42.7K
EBS icon
111
Emergent Biosolutions
EBS
$373M
$585K 0.15%
+8,885
New +$573K
UIS icon
112
Unisys
UIS
$209M
$585K 0.15%
+28,654
New +$451K
RL icon
113
Ralph Lauren
RL
$22.6B
$568K 0.14%
+4,128
New +$487K
NRG icon
114
NRG Energy
NRG
$28.3B
$564K 0.14%
15,091
-77,136
-84% -$2.95M
PGR icon
115
Progressive
PGR
$123B
$562K 0.14%
+7,915
New +$527K
ICFI icon
116
ICF International
ICFI
$1.46B
$557K 0.14%
7,388
-502
-6% -$35.2K
GILD icon
117
Gilead Sciences
GILD
$162B
$556K 0.14%
+7,198
New +$503K
BMY icon
118
Bristol-Myers Squibb
BMY
$133B
$552K 0.14%
+8,884
New +$477K
PCAR icon
119
PACCAR
PCAR
$69.8B
$539K 0.13%
+11,867
New +$474K
CSX icon
120
CSX Corp
CSX
$93.4B
$535K 0.13%
+21,657
New +$498K
ALL icon
121
Allstate
ALL
$68B
$527K 0.13%
+5,344
New +$480K
GWW icon
122
W.W. Grainger
GWW
$65.3B
$522K 0.13%
1,461
+27
+2% +$8.03K
CPRI icon
123
Capri Holdings
CPRI
$1.83B
$514K 0.13%
+7,496
New +$377K
CMA
124
DELISTED
Comerica
CMA
$500K 0.12%
5,543
-31,297
-85% -$2.49M
REGN icon
125
Regeneron Pharmaceuticals
REGN
$78.5B
$495K 0.12%
+1,225
New +$448K

Similar funds

USA Financial Formulas's Q4 2018 Portfolio in Review

As of Q4 2018, USA Financial Formulas held 446 positions worth $402M, up 1.7% from $395M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

USA Financial Formulas withdrew a net $20.3M in Q4 2018, closing 119 positions and reducing 107 holdings. Its most notable exit was Cisco, an estimated $14.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 8.9% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, USA Financial Formulas opened a new position in Apple worth $12.1M.

  • USA Financial Formulas's largest Q4 2018 buy was Apple: 214,016 shares worth $12.1M.
  • USA Financial Formulas added most to Intuitive Surgical in Q4 2018, an estimated $7M increase.
  • USA Financial Formulas's biggest Q4 2018 reduction was Intel, cutting an estimated $13.3M.
  • USA Financial Formulas fully exited Cisco in Q4 2018, selling an estimated $14.9M.
  • USA Financial Formulas's ten largest holdings make up 24% of its $402M portfolio in Q4 2018.
  • USA Financial Formulas opened 176 new positions and closed 119 in Q4 2018.
  • USA Financial Formulas's portfolio value rose 1.7% quarter-over-quarter to $402M.

Based on USA Financial Formulas's 13F filing for Q4 2018, filed 14 Feb 2019.